Highlight Therapeutics

News

Cancer immunotherapy has set new standards in care, with some impressive responses in those patients lucky enough to respond.

News

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.